Stephanie BIGOU & Delphine BOHL

  • Stephanie BIGOU holds a Master’s degree in Cell Biology and Animal Physiology from University Montpellier II (2002). In 2005, she was recruited as an Engineer at Institut Pasteur of Paris in an INSERM unit where she participated in a project of gene therapy for a neurodegenerative disease, and studied its In 2011 she joined the ICM in the team of Dr. Olga Corti to study Parkinson’s disease in murine and iPSc models, and she help setting up the iPS activity of the cell culture core facility. At the end of 2013 she joined the CELIS-iPS activity to become its operational manager in 2015.


  • Delphine BOHL holds a PhD in virology and gene therapy from University Paris 7 (1997), carried out in the department of neuroscience at Institut Pasteur of Paris. In 1998, she was recruited as an assistant professor within an INSERM unit at Institut Pasteur where she developed a solid expertise in human iPS cell technology used to model neurodegenerative disorders. She became an associate professor in 2000. Since January 2014, she is a member of the “ALS causes and mechanisms of motor neuron degeneration” team at the ICM and the scientific manager of CELIS-iPS activity.